Home > Boards > US Listed > Medical - Drugs > Flexion Therapeutics, Inc. (FLXN)

Holders of Record

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TREND1 Member Profile
Member Level 
Followed By 412
Posts 55,045
Boards Moderated 22
Alias Born 12/16/01
160x600 placeholder
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 11/6/2020 4:30:00 PM
Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference GlobeNewswire Inc. - 11/5/2020 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2020 4:03:18 PM
Flexion Therapeutics Reports Third-Quarter 2020 Financial Results and Recent Business Highlights GlobeNewswire Inc. - 11/4/2020 4:01:00 PM
Flexion Therapeutics to Report Third-Quarter 2020 Financial Results on November 4, 2020 GlobeNewswire Inc. - 10/29/2020 4:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2020 7:06:10 AM
Flexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA® Net Sales of Approximately $23.6 Million GlobeNewswire Inc. - 10/13/2020 6:59:10 AM
Flexion Therapeutics to Present at the 2020 Cell & Gene Virtual Meeting on the Mesa GlobeNewswire Inc. - 10/8/2020 4:30:10 PM
Flexion Therapeutics Announces Podium Presentation of FX301 Preclinical Data at Virtual ANESTHESIOLOGY 2020 Meeting GlobeNewswire Inc. - 10/5/2020 9:00:10 AM
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 10/2/2020 4:30:10 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/21/2020 3:28:12 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/11/2020 4:21:53 PM
Flexion Therapeutics to Present at the H.C. Wainwright Virtual Healthcare Conference GlobeNewswire Inc. - 9/9/2020 4:30:10 PM
Flexion Therapeutics Announces Treatment of First Patient in Second Cohort of FX201 Phase 1 Dose-Escalation Trial GlobeNewswire Inc. - 9/8/2020 4:30:10 PM
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 9/4/2020 4:30:10 PM
Flexion Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference GlobeNewswire Inc. - 9/3/2020 4:30:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2020 4:48:13 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/20/2020 4:46:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2020 5:01:03 PM
Flexion Therapeutics Announces Appointment of Liz Kwo, MD, to its Board of Directors GlobeNewswire Inc. - 8/19/2020 9:00:10 AM
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 8/7/2020 4:30:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2020 4:23:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 4:07:09 PM
Flexion Therapeutics Reports Second-Quarter 2020 Financial Results and Recent Business Highlights GlobeNewswire Inc. - 8/5/2020 4:01:10 PM
Flexion Therapeutics to Report Second-Quarter 2020 Financial Results on August 5, 2020 GlobeNewswire Inc. - 7/30/2020 4:30:10 PM
TREND1 Member Level  Thursday, 03/23/17 01:45:08 PM
Re: None
Post # of 69 
Holders of Record

As of March 2, 2017, there were approximately 25 stockholders of record of our common stock. Certain shares are held in “street” name and accordingly, the number of beneficial owners of such shares is not known or included in the foregoing number.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences